Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar romad829 (33.81) Submitted: 8/9/2007 8:25:04 PM : Outperform Start Price: $15.81 FLML Score: -68.60

I think this is about as low as it will get.

Featured Broker Partners


Advertisement